title: Molecular targets in lymphomas.
abstract: A large proportion of patients with lymphomas are curable with standard chemotherapy. There is a plateau, however, in cure rate with chemotherapy alone. Advances in molecular biology have led to a better understanding of the pathogenesis of lymphomas. This article provides examples of how molecular therapy is going to change the treatment of lymphomas.
authors.affiliation: Yale University School of Medicine, New Haven, CT, USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Psyrri
authors.forename: Theofanis
authors.initials: T
authors.lastname: Economopoulos
mesh_terms: D000818:Animals; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*